Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.

Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM.

Lancet. 1998 May 16;351(9114):1472-6.

PMID:
9605803
2.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
3.

Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.

Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C.

P N G Med J. 2001 Mar-Jun;44(1-2):6-16.

PMID:
12418673
4.

Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.

Huebner RE, Nicol M, Mothupi R, Käyhty H, Mbelle N, Khomo E, Klugman KP.

Vaccine. 2004 Dec 21;23(6):802-6.

PMID:
15542205
5.
7.
8.
13.

Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).

Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1115-9.

14.

Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.

Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.

Pediatrics. 2006 Apr;117(4):e717-24. Epub 2006 Mar 20.

PMID:
16549502
15.

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.

Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B.

Lancet. 1997 Apr 26;349(9060):1191-7. Erratum in: Lancet 1997 Aug 16;350(9076):524.

PMID:
9130939
16.

Antibody response to Haemophilus influenzae type b tetanus conjugate vaccine with two doses given at 3 and 5 months of age.

Guimarães T, Cereda RF, Bianchin PJ, Nagao AT, Sampaio MC, Mendonça JS.

Int J Infect Dis. 2002 Jun;6(2):113-7.

17.

Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger.

Campagne G, Garba A, Schuchat A, Boulanger D, Plikaytis BD, Ousseini M, Chippaux JP.

Am J Trop Med Hyg. 1998 Nov;59(5):837-42.

PMID:
9840608
18.

Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.

Capeding MR, Nohynek H, Käyhty H, Pascual LG, Sunico ES, Tamundong AA, Ruutu P.

Vaccine. 1998 May-Jun;16(9-10):1004-8.

PMID:
9682351
19.

Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey.

Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakök K, Silier T, Dupuy M, Pehlivan T, Ozmert E, Desmyter J.

Vaccine. 1999 Feb 26;17(7-8):875-86.

PMID:
10067694
20.

Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.

Peltola H, Eskola J, Käyhty H, Takala AK, Mäkelä PH.

Arch Pediatr Adolesc Med. 1994 Jun;148(6):620-5.

PMID:
8193690

Supplemental Content

Support Center